12-year-old Caleb Chung who volunteered to be part of the Pfizer COVID-19 vaccine study for younger adults 12-15-years-old – early results show the vaccine to be 100% effective.

March 31, 2021
Featured article image

“Usually I’m just at home doing online school and there’s not much I can really do to fight back against the virus.”

  • The information about this study is not yet published – The data being quoted in headlines around the world is based on Pfizer’s press release.
  • Pfizer says 18 cases of COVID-19 were diagnosised in the placebo group versus zero cases in those receiving the vaccine. The study included 2,260 teens.
  • The Pfizer vaccine is currently granted Emergency Use Authorization (EUA) for those 16-and-older.
  • Pfizer says it will ask the FDA for EUA of the vaccine for those 12-and-older within weeks.
  • Just over 1 in 10 cases of COVID-19 in America are children.
  • Why This Matters: While U.S. officials floated the idea of vaccinating high schoolers in the Fall of 2021, this could potentially move up the timeline for when the COVID-19 vaccine is available to those 12 and older.

Pfizer says its COVID-19 vaccine protects younger teens

by Jenna Lee,

ImageImageImageImage